Cargando…
Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop
BACKGROUND AND PURPOSE: Transient receptor potential melastatin 3 (TRPM3) is a non‐selective cation channel that plays a pivotal role in the peripheral nervous system as a transducer of painful heat signals. Alternative splicing gives rise to several TRPM3 variants. The functional consequences of th...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290681/ https://www.ncbi.nlm.nih.gov/pubmed/32780479 http://dx.doi.org/10.1111/bph.15223 |
_version_ | 1784748962557722624 |
---|---|
author | Held, Katharina Aloi, Vincenzo Davide Freitas, Ana Cristina Nogueira Janssens, Annelies Segal, Andrei Przibilla, Julia Philipp, Stephan Ernst Wang, Yu Tian Voets, Thomas Vriens, Joris |
author_facet | Held, Katharina Aloi, Vincenzo Davide Freitas, Ana Cristina Nogueira Janssens, Annelies Segal, Andrei Przibilla, Julia Philipp, Stephan Ernst Wang, Yu Tian Voets, Thomas Vriens, Joris |
author_sort | Held, Katharina |
collection | PubMed |
description | BACKGROUND AND PURPOSE: Transient receptor potential melastatin 3 (TRPM3) is a non‐selective cation channel that plays a pivotal role in the peripheral nervous system as a transducer of painful heat signals. Alternative splicing gives rise to several TRPM3 variants. The functional consequences of these splice isoforms are poorly understood. Here, the pharmacological properties of TRPM3 variants arising from alternative splicing in the pore‐forming region were compared. EXPERIMENTAL APPROACH: Calcium microfluorimetry and patch clamp recordings were used to compare the properties of heterologously expressed TRPM3α1 (long pore variant) and TRPM3α2–α6 (short pore variants). Furthermore, site‐directed mutagenesis was done to investigate the influence of the length of the pore loop on the channel function. KEY RESULTS: All short pore loop TRPM3α variants (TRPM3α2–α6) were activated by the neurosteroid pregnenolone sulphate (PS) and by nifedipine, whereas the long pore loop variant TRPM3α1 was insensitive to either compound. In contrast, TRPM3α1 was robustly activated by clotrimazole, a compound that does not directly activate the short pore variants but potentiates their responses to PS. Clotrimazole‐activated TRPM3α1 currents were largely insensitive to established TRPM3α2 antagonists and were only partially inhibited upon activation of the μ opioid receptor. Finally, by creating a set of mutant channels with pore loops of intermediate length, we showed that the length of the pore loop dictates differential channel activation by PS and clotrimazole. CONCLUSION AND IMPLICATIONS: Alternative splicing in the pore‐forming region of TRPM3 defines the channel's pharmacological properties, which depend critically on the length of the pore‐forming loop. LINKED ARTICLES: This article is part of a themed issue on Structure Guided Pharmacology of Membrane Proteins (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.14/issuetoc |
format | Online Article Text |
id | pubmed-9290681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92906812022-07-20 Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop Held, Katharina Aloi, Vincenzo Davide Freitas, Ana Cristina Nogueira Janssens, Annelies Segal, Andrei Przibilla, Julia Philipp, Stephan Ernst Wang, Yu Tian Voets, Thomas Vriens, Joris Br J Pharmacol Article BACKGROUND AND PURPOSE: Transient receptor potential melastatin 3 (TRPM3) is a non‐selective cation channel that plays a pivotal role in the peripheral nervous system as a transducer of painful heat signals. Alternative splicing gives rise to several TRPM3 variants. The functional consequences of these splice isoforms are poorly understood. Here, the pharmacological properties of TRPM3 variants arising from alternative splicing in the pore‐forming region were compared. EXPERIMENTAL APPROACH: Calcium microfluorimetry and patch clamp recordings were used to compare the properties of heterologously expressed TRPM3α1 (long pore variant) and TRPM3α2–α6 (short pore variants). Furthermore, site‐directed mutagenesis was done to investigate the influence of the length of the pore loop on the channel function. KEY RESULTS: All short pore loop TRPM3α variants (TRPM3α2–α6) were activated by the neurosteroid pregnenolone sulphate (PS) and by nifedipine, whereas the long pore loop variant TRPM3α1 was insensitive to either compound. In contrast, TRPM3α1 was robustly activated by clotrimazole, a compound that does not directly activate the short pore variants but potentiates their responses to PS. Clotrimazole‐activated TRPM3α1 currents were largely insensitive to established TRPM3α2 antagonists and were only partially inhibited upon activation of the μ opioid receptor. Finally, by creating a set of mutant channels with pore loops of intermediate length, we showed that the length of the pore loop dictates differential channel activation by PS and clotrimazole. CONCLUSION AND IMPLICATIONS: Alternative splicing in the pore‐forming region of TRPM3 defines the channel's pharmacological properties, which depend critically on the length of the pore‐forming loop. LINKED ARTICLES: This article is part of a themed issue on Structure Guided Pharmacology of Membrane Proteins (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.14/issuetoc John Wiley and Sons Inc. 2020-08-28 2022-07 /pmc/articles/PMC9290681/ /pubmed/32780479 http://dx.doi.org/10.1111/bph.15223 Text en © 2020 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Article Held, Katharina Aloi, Vincenzo Davide Freitas, Ana Cristina Nogueira Janssens, Annelies Segal, Andrei Przibilla, Julia Philipp, Stephan Ernst Wang, Yu Tian Voets, Thomas Vriens, Joris Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop |
title | Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop |
title_full | Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop |
title_fullStr | Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop |
title_full_unstemmed | Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop |
title_short | Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop |
title_sort | pharmacological properties of trpm3 isoforms are determined by the length of the pore loop |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290681/ https://www.ncbi.nlm.nih.gov/pubmed/32780479 http://dx.doi.org/10.1111/bph.15223 |
work_keys_str_mv | AT heldkatharina pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop AT aloivincenzodavide pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop AT freitasanacristinanogueira pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop AT janssensannelies pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop AT segalandrei pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop AT przibillajulia pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop AT philippstephanernst pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop AT wangyutian pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop AT voetsthomas pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop AT vriensjoris pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop |